Physicochemical Properties
| Molecular Formula | C10H11NAO4 |
| Molecular Weight | 218.18 |
| Exact Mass | 196.073 |
| CAS # | 150436-68-3 |
| PubChem CID | 23670520 |
| Appearance | White to off-white solid powder |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 331.6±17.0 °C at 760 mmHg |
| Flash Point | 130.3±14.4 °C |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.521 |
| LogP | 1.65 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 15 |
| Complexity | 190 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | SKORRGYRKQDXRS-UHFFFAOYSA-M |
| InChi Code | InChI=1S/C10H12O4.Na/c1-7(10(11)12)14-9-5-3-8(13-2)4-6-9;/h3-7H,1-2H3,(H,11,12);/q;+1/p-1 |
| Chemical Name | sodium;2-(4-methoxyphenoxy)propanoate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | T1R3[1] |
| ln Vitro | In mouse pancreatic β-cell MIN6 (IC50~4 mM), lactisole (3-10 mM; 48 h) suppresses insulin secretion produced by acesulfame-K, sucrose, and glycophorin [1]. Without altering the rise in intracellular cAMP concentration ([cAMP]c), lactisole (5 mM; 48 h) reduces the increase in cytoplasmic Ca2+ concentration ([Ca2+]c) brought on by sucrose and acesulfame-K [1]. |
| References |
[1]. Lactisole inhibits the glucose-sensing receptor T1R3 expressed in mouse pancreatic β-cells. J Endocrinol. 2015 Jul;226(1):57-66. [2]. Sweet Taste Antagonist Lactisole Administered in Combination with Sucrose, But Not Glucose, Increases Energy Intake and Decreases Peripheral Serotonin in Male Subjects. Nutrients. 2020 Oct 14;12(10):3133. |
Solubility Data
| Solubility (In Vitro) | DMSO: 125 mg/mL (572.92 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (9.53 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (9.53 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (9.53 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.5834 mL | 22.9169 mL | 45.8337 mL | |
| 5 mM | 0.9167 mL | 4.5834 mL | 9.1667 mL | |
| 10 mM | 0.4583 mL | 2.2917 mL | 4.5834 mL |